- Home
- RZLT vs STRO Comparison
RZLT vs STRO Comparison
Compare RZLT & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- STRO
- Stock Information
- Founded
- RZLT 2010
- STRO 2003
- Country
- RZLT United States
- STRO United States
- Employees
- RZLT N/A
- STRO N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RZLT Health Care
- STRO Health Care
- Exchange
- RZLT Nasdaq
- STRO Nasdaq
- Market Cap
- RZLT 361.3M
- STRO 77.7M
- IPO Year
- RZLT N/A
- STRO 2018
- Fundamental
- Price
- RZLT $4.82
- STRO $0.76
- Analyst Decision
- RZLT Strong Buy
- STRO Hold
- Analyst Count
- RZLT 6
- STRO 7
- Target Price
- RZLT $12.00
- STRO $3.97
- AVG Volume (30 Days)
- RZLT 1.4M
- STRO 1.4M
- Earning Date
- RZLT 05-13-2025
- STRO 08-12-2025
- Dividend Yield
- RZLT N/A
- STRO N/A
- EPS Growth
- RZLT N/A
- STRO N/A
- EPS
- RZLT N/A
- STRO N/A
- Revenue
- RZLT N/A
- STRO $66,434,000.00
- Revenue This Year
- RZLT $35.39
- STRO N/A
- Revenue Next Year
- RZLT N/A
- STRO N/A
- P/E Ratio
- RZLT N/A
- STRO N/A
- Revenue Growth
- RZLT N/A
- STRO N/A
- 52 Week Low
- RZLT $2.22
- STRO $0.52
- 52 Week High
- RZLT $6.19
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- RZLT 67.57
- STRO 44.92
- Support Level
- RZLT $4.15
- STRO $0.67
- Resistance Level
- RZLT $4.71
- STRO $0.79
- Average True Range (ATR)
- RZLT 0.27
- STRO 0.07
- MACD
- RZLT 0.04
- STRO -0.01
- Stochastic Oscillator
- RZLT 89.36
- STRO 34.52
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.